Literature DB >> 25537220

TP53 codon 72 single nucleotide polymorphism in chronic lymphocytic leukemia.

N I Bilous1, I V Abramenko1, A A Chumak1, I S Dyagil1, Z V Martіna1.   

Abstract

UNLABELLED: Defects in the tumor suppressor gene TP53 are known to be important in chronic lymphocytic leukemia (CLL) and TP53 inactivation is associated with a particularly aggressive form of the disease. The single nucleotide polymorphism in the TP53 gene at codon 72 (rs1042522), results in amino acid substitution influencing apoptotic potential of TP53 protein. The aim of the study was to evaluate the association of the TP53 codon 72 polymorphism and incidence of TP53 mutations in CLL patients.
METHODS: 261 CLL samples were analyzed by polymerase chain reaction and direct sequencing for TP53 mutations and single nucleotide polymorphism.
RESULTS: The 72Pro/Pro genotype was associated with an increased incidence of TP53 mutations in previously treated patients (OR = 2.503; 95% CI 1.142-5.487; р = 0.001).
CONCLUSION: This study revealed that the TP53 codon 72 polymorphism may be used as a risk factor for incidence of TP53 mutations in CLL.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25537220

Source DB:  PubMed          Journal:  Exp Oncol        ISSN: 1812-9269


  2 in total

1.  Role of a p53 polymorphism in the development of nonfunctional pituitary adenomas.

Authors:  Garima Yagnik; Arman Jahangiri; Rebecca Chen; Jeffrey R Wagner; Manish K Aghi
Journal:  Mol Cell Endocrinol       Date:  2017-02-16       Impact factor: 4.102

2.  TP53 Gene 72 Arg/Pro (rs1042522) Single Nucleotide Polymorphism Contribute to Increase the Risk of B-Chronic Lymphocytic Leukemia in the Sudanese Population

Authors:  Ameen Abdulaziz Mohammed Basabaeen; Enaam Abdalrhman Abdelgader; Ebtihal Ahmed Babekir; Saadia Osman Abdelrahim; Nada Hassan Eltayeb; Osama Ali Altayeb; Eman Abbass Fadul; Abdulwali Sabo; Ibrahim Khider Ibrahim
Journal:  Asian Pac J Cancer Prev       Date:  2019-05-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.